Transactions in Zealand Pharma shares by company executives, ongoing drug development and commercial partnerships

From GlobeNewswire: 2024-12-25 11:40:00

Zealand Pharma A/S has announced transactions in its shares by persons discharging managerial responsibilities. The Copenhagen-based biotechnology company focuses on peptide-based medicines with more than 10 drug candidates in clinical development. Two have reached the market, and three are in late-stage development. Zealand Pharma has partnerships with pharmaceutical companies and commercial partnerships for its marketed products. For more information, visit their website. Contact their Investor Relations Manager Neshat Ahmadi or Investor Relations Officer Adam Lange for further details. VP of Investor Relations & Corporate Communications, Anna Krassowska, can also provide information.



Read more at GlobeNewswire: Transactions in Zealand Pharma shares and/or related